Regulation & Policy
In this section you will find Regulation & Policy market research reports and publications. These provide information on the latest products, news, market growth forecasts, data and business opportunities of value to your organization.
7 Item(s)
per page
-
Out of Pocket Healthcare Spending 2011
€1,534.00Published by Kalorama Information on Apr 22nd, 2011The costs of health care products and services continue to rise briskly, significantly outpacing currently low inflation rates. According to the U.S. Department of Labor, the average household’s spending on... Learn More -
Pharmaceutical Anti-counterfeiting Technologies: Market Analysis 2011-2021
€1,968.00Published by Visiongain on Apr 11th, 2011do you want to discover the opportunities there? What are the commercial prospects for pharmaceutical anti-counterfeiting technology? Our new report shows you that industry and market’s revenue potential from... Learn More -
Partnering & M&A Agreements in Pharma and Biotech Yearbook 2010
€2,160.00Published by CurrentPartnering on Jan 26th, 2011The Partnering and M&A Deals in Pharma and Biotech Yearbook 2010 report provides comprehensive understanding and unprecedented access to the partnering and M&A deals and agreements entered into... Learn More -
Pharmacovigilance and Other Pharma Regulatory Developments 2010-2020
€1,739.00Published by Visiongain on Sep 9th, 2010What will this decade hold for pharma regulatory affairs? What regulatory demands will pharma companies face from 2010 to 2020? Our new study will show you developments in pharma regulations... Learn More -
Obama's Healthcare Reform Bill and its Impact on the U.S. Healthcare Market
€3,720.00Published by on Aug 16th, 2010According to World Health Organization, the U.S. healthcare system ranks 37th among the healthcare systems of 200 countries. The U.S. healthcare spending is considered as one of the highest in... Learn More -
Pharmaceutical Anti-counterfeiting Strategies and Commercial Analysis 2010-2020
€1,739.00Published by Visiongain on May 28th, 2010how will the industry and regulators stem the tide of counterfeits? The pharmaceutical anti-counterfeiting market has been generating increasing revenues in recent years, with strong growth to come, as... Learn More -
Biosimilars and Follow-On Biologics Report: The Global Outlook 2009-2024
€1,739.00Published by Visiongain on Apr 16th, 2009There is great demand for lower-cost biological drugs: commercial and regulatory developments will make biosimilars and follow-on biologics a success – our new report explains how. Learn More
7 Item(s)
per page